Both journals are anchored in large scientific societies and serve basically the same medical , physical and biological community and at the same scientific level ; the two journals are in the most recent Impact Factor list ranked almost back to back , indicating an equal importance and contribution to science .
Radiotherapy and Oncology is more than a scientific journal , it also serves other purpose s such as facilitate education through ( educational ) review s and improving the st and ard of care by bringing forward guidelines for conduct of radiotherapy .
Finally , the journal also tries to maintain a communication platform between the science produced by the membership of ESTRO and therefore it brings papers frommembers in the different European countries , sometimes at the expense of ultimate scientific quality , but with the underst and ing that it is important that the entire ESTRO membership gets access and opportunity to publish in a high ranked journal .
ESTRO , the European Society for Therapeutic Radiation Oncology , or with its new name European Society for Radiation Oncology , is a scientific society .
It means that the prime aim of ESTRO is to bring to bring people together on an individual basis who have a common interest in improving the scientific conduct of radiotherapy and cancer treatment in Europe by ensuring that proper radiotherapy is available in the multidisciplinary treatment of cancer and applied with the right indication and with the most optimal technique .
One of the main aims of this endeavour was to create a platform for scientific exchange through meetings and through the establishment of a scientific journal [ 1 ] .
Thus Radiotherapy and Oncology was launched shortly after the foundation of ESTRO and has become the society ’s prime vehicle for scientific communication by serving ESTRO members through almost the entire 30 years of the society ’s existence .
The aim was to create a peer review ed high quality international journal and that aim has indeed been fulfilled . ‘ ‘
Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders.
BACKGROUND AND PURPOSE To report an early analysis of prospect i ve study exploring preoperative radiotherapy and local excision in rectal cancer . MATERIAL S AND METHODS Mucosa at tumour edges was tattooed . Patients with cT1 - 3N0 tumour < 3 - 4 cm were treated with either 5x5Gy+4Gy boost ( N=31 ) or chemoradiation ( 50.4Gy+5.4Gy boost , 1.8Gy per fraction+5-fluorouracyl and leucovorin ; N=13 ) . Thirteen patients from the short-course group were unfit for chemotherapy .  The interval from radiation to full-thickness local excision was 6 weeks . The protocol called for conversion to a transabdominal surgery in case of ypT2 - 3 disease or positive margin . RESULTS The postoperative complications requiring hospitalization were recorded in 9 % of patients . The rate of pathological complete response was 41 % . The rate of patients requiring conversion was 34 % ; however , 18 % actually underwent conversion and the remaining 16 % refused or were unfit . During the 14 months of median follow-up , local recurrence was detected in 7 % of patients and all underwent salvage surgery . Of 19 patients in whom initially anterior resection was likely , 16 % had abdominoperineal resection performed for a conversion or as a rescue procedure . CONCLUSION Our study suggests that the short-course radiation prior to local excision is a treatment option for high-risk patients
Both journals are anchored in large scientific societies and serve basically the same medical , physical and biological community and at the same scientific level ; the two journals are in the most recent Impact Factor list ranked almost back to back , indicating an equal importance and contribution to science .
Radiotherapy and Oncology is more than a scientific journal , it also serves other purpose s such as facilitate education through ( educational ) review s and improving the st and ard of care by bringing forward guidelines for conduct of radiotherapy .
Finally , the journal also tries to maintain a communication platform between the science produced by the membership of ESTRO and therefore it brings papers frommembers in the different European countries , sometimes at the expense of ultimate scientific quality , but with the underst and ing that it is important that the entire ESTRO membership gets access and opportunity to publish in a high ranked journal .
ESTRO , the European Society for Therapeutic Radiation Oncology , or with its new name European Society for Radiation Oncology , is a scientific society .
It means that the prime aim of ESTRO is to bring to bring people together on an individual basis who have a common interest in improving the scientific conduct of radiotherapy and cancer treatment in Europe by ensuring that proper radiotherapy is available in the multidisciplinary treatment of cancer and applied with the right indication and with the most optimal technique .
One of the main aims of this endeavour was to create a platform for scientific exchange through meetings and through the establishment of a scientific journal [ 1 ] .
Thus Radiotherapy and Oncology was launched shortly after the foundation of ESTRO and has become the society ’s prime vehicle for scientific communication by serving ESTRO members through almost the entire 30 years of the society ’s existence .
The aim was to create a peer review ed high quality international journal and that aim has indeed been fulfilled . ‘ ‘